These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19772395)

  • 21. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
    Juluri A; Peddikotla P; Repka MA; Murthy SN
    J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: quantification of the drug localized in skin.
    Paturi J; Kim HD; Chakraborty B; Friden PM; Banga AK
    J Drug Target; 2010 Feb; 18(2):134-40. PubMed ID: 19772394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery.
    Prasad R; Anand S; Khar RK; Dinda AK; Koul V
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1281-92. PubMed ID: 19832628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible skin permeabilization for transdermal delivery of macromolecules.
    Prausnitz MR
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):455-83. PubMed ID: 9450177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal delivery of proteins.
    Kalluri H; Banga AK
    AAPS PharmSciTech; 2011 Mar; 12(1):431-41. PubMed ID: 21369712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of methotrexate for pediatrics using silicon microneedles.
    Abla MJ; Chaturvedula A; O'Mahony C; Banga AK
    Ther Deliv; 2013 May; 4(5):543-51. PubMed ID: 23647273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide dendrimer-conjugates of ketoprofen: Synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery.
    Hegde AR; Rewatkar PV; Manikkath J; Tupally K; Parekh HS; Mutalik S
    Eur J Pharm Sci; 2017 May; 102():237-249. PubMed ID: 28285173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
    Wong TW
    J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of physical and chemical enhancement techniques for transdermal delivery of linagliptin.
    Karve T; Banga AK
    Int J Pharm; 2024 Apr; 654():123992. PubMed ID: 38479485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: a review.
    Han T; Das DB
    Eur J Pharm Biopharm; 2015 Jan; 89():312-28. PubMed ID: 25541440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation.
    Lanke SS; Kolli CS; Strom JG; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):26-33. PubMed ID: 18801420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
    Prasad R; Koul V; Anand S; Khar RK
    Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent.
    Vemulapalli V; Yang Y; Siddoju S; Conjeevaram R; Teunissen H; Myers T; Banga AK
    Int J Pharm; 2011 Nov; 420(1):20-5. PubMed ID: 21856395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irontophoresis: transdermal delivery of iron by iontophoresis.
    Murthy SN; Vaka SR
    J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of iontophoretic parameters for the transdermal delivery of methotrexate.
    Vemulapalli V; Banga AK; Friden PM
    Drug Deliv; 2008 Sep; 15(7):437-42. PubMed ID: 18712621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.
    Dragicevic N; Maibach H
    Adv Drug Deliv Rev; 2018 Mar; 127():58-84. PubMed ID: 29425769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.